- EHF is a novel regulator of cellular redox metabolism and predicts patient prognosis in HNSCC
Akinsola Oyelakin et al, 2022, NAR Cancer CrossRef - Identification of novel activators of the metal responsive transcription factor (MTF-1) using a gene expression biomarker in a microarray compendium
Abigail C Jackson et al, 2020, Metallomics CrossRef - Latent Kaposi’s sarcoma-associated herpesvirus infection in bladder cancer cells promotes drug resistance by reducing reactive oxygen species
Suhyuk Lee et al, 2016, Journal of Microbiology CrossRef - Molecular Dissection of Induced Platinum Resistance through Functional and Gene Expression Analysis in a Cell Culture Model of Bladder Cancer
Sisi Wang et al, 2016, PLOS ONE CrossRef - Aldo-keto reductase 1C1 induced by interleukin-1β mediates the invasive potential and drug resistance of metastatic bladder cancer cells
Ryuji Matsumoto et al, 2016, Scientific Reports CrossRef - Comparative proteomics analysis of whey fractions from Korean mother's milk with different gender babies in the northeast China
Boxue Xia et al, 2024, International Journal of Dairy Technology CrossRef - SILAC‐based quantitative proteomic analysis reveals widespread molecular alterations in human skin keratinocytes upon chronic arsenic exposure
Sartaj Ahmad Mir et al, 2017, PROTEOMICS CrossRef - Analysis of the mechanism of aldo-keto reductase dependent cis-platin resistance in HepG2 cells based on transcriptomic and NADH metabolic state
TINGTING SUN et al, 2023, BIOCELL CrossRef - VEGF-C inhibition reverses resistance of bladder cancer cells to cisplatin via upregulating maspin
HAIPENG ZHU et al, 2015, Molecular Medicine Reports CrossRef - Drug-induced oxidative stress in cancer treatments: Angel or devil?
Hao Jiang et al, 2023, Redox Biology CrossRef - Aberrant expression of claudin‐6 contributes to malignant potentials and drug resistance of cervical adenocarcinoma
Yui Ito et al, 2022, Cancer Science CrossRef - The effect of the alpha-specific PI3K inhibitor alpelisib combined with anti-HER2 therapy in HER2+/PIK3CA mutant breast cancer
Maria Letizia Cataldo et al, 2023, Frontiers in Oncology CrossRef - Integrated data analysis reveals significant associations of KEAP1 mutations with DNA methylation alterations in lung adenocarcinomas
Mohamed Elshaer et al, 2020, Aging CrossRef - Transcriptomic insights into the zinc homeostasis of MCF-7 breast cancer cells via next-generation RNA sequencing
Mohammad S Zaman et al, 2021, Metallomics CrossRef - Elucidating Role of Reactive Oxygen Species (ROS) in Cisplatin Chemotherapy: A Focus on Molecular Pathways and Possible Therapeutic Strategies
Sepideh Mirzaei et al, 2021, Molecules CrossRef - Label-Free Quantitative Proteomics Analysis of the Sorafenib Resistance in HepG2 Cells
Zi-Xuan Wang et al, 2022, Journal of Analysis and Testing CrossRef - AKR1C2 acts as a targetable oncogene in esophageal squamous cell carcinoma via activating PI3K/AKT signaling pathway
Zhan‐Fei Zhang et al, 2020, Journal of Cellular and Molecular Medicine CrossRef - Investigation of the Potential of Bile Acid Methyl Esters as Inhibitors of Aldo‐keto Reductase 1C2: Insight from Molecular Docking, Virtual Screening, Experimental Assays and Molecular Dynamics
Maja A. Marinović et al, 2022, Molecular Informatics CrossRef - Emodin mitigates the oxidative stress induced by cisplatin in osteosarcoma MG63 cells
Li Yan et al, 2016, Oncology Letters CrossRef - Inhibition of IGFBP-2 improves the sensitivity of bladder cancer cells to cisplatin via upregulating the expression of maspin
HAIPENG ZHU et al, 2015, International Journal of Molecular Medicine CrossRef - Cisplatin-Resistant Urothelial Bladder Cancer Cells Undergo Metabolic Reprogramming beyond the Warburg Effect
Julieta Afonso et al, 2024, Cancers CrossRef